Covista Inc. CVSA
- Headquarters
- Chicago, IL
- CEO
- Stephen W. Beard
- Next results
- around Jan 27, 2027
Where each dollar of revenue went, FY2026
Revenue of $2.0B through the costs to a net profit of $251.6M · income statement of the 10-K
CVSA among Consumer discretionary peers
Six ratios from the latest 10-K. Each corner is the share of 168 peers the company is above, not a score.
What changed
16 new risk paragraphs. 10-K filed Aug 6, 2026 against Aug 7, 2025.
Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.
Accounting checks
10 checks on the latest 10-K. Checks, not verdicts.
0facts worth reading about all 10 checks found nothing to note
-
Receivables +16.3% ($143.4M to $166.9M) vs revenue +9.3% ($1.8B to $2.0B), +7.1 pts apart
-
Cash from operations $470.4M vs net income $251.6M (FY ending Jun 30, 2026)
-
Same auditor in both 10-Ks: PricewaterhouseCoopers LLP
7 more checks with nothing to note
-
No statement of substantial doubt about going concern
-
No 8-K item 4.02 in the last 2 years
-
No NT 10-K or NT 10-Q in the last 2 years
-
No longer listed: Goodwill Impairment Assessment - Ross University School of Medicine (“RUSM”) Reporting Unit
-
No sentence in the 10-K concludes that controls were not effective because of a material weakness
-
No 8-K item 2.06 in the last 2 years
-
No 8-K item 1.03 in the last 2 years
In their words
16 paragraphs in Risk Factors that were not in the 10-K filed Aug 7, 2025. Quoted as filed.
-
Item 1A · new paragraph · not in the 10-K filed Aug 7, 2025 10-K, ITEM 1A
Due to the regulatory and enforcement efforts at times directed at all Title IV participating institutions and adverse publicity arising from such efforts, we may face additional government and regulatory investigations and actions, lawsuits from private plaintiffs, and shareholder class actions and derivative claims. We may incur…
-
Item 1A · new paragraph · not in the 10-K filed Aug 7, 2025 10-K, ITEM 1A
Recent changes to federal student loan programs that reduce annual, aggregate, and lifetime borrowing limits and limit federal student aid for part-time students may limit students’ ability to finance their education, which may in turn materially and adversely affect our results of operations. There have been recent changes to federal…
-
Item 1A · new paragraph · not in the 10-K filed Aug 7, 2025 10-K, ITEM 1A
In addition, if one of our Title IV institutions were to close, we could be subject to liabilities arising from closed school discharge claims. Under applicable regulations, students who do not complete their programs due to a qualifying institutional closure may be eligible for loan discharges, and ED may seek to recover the amount of…
-
Item 1A · new paragraph · not in the 10-K filed Aug 7, 2025 10-K, ITEM 1A
If we, or one of the companies that service our credit programs, do not comply with laws applicable to the financing programs that assist our students in affording our educational offerings, including Truth in Lending and Fair Debt
New risk paragraphs, against peers
Latest 10-K of each, Consumer discretionary companies closest in revenue
Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.
Financial performance
Last 4 fiscal years · 10-K XBRL
| Metric | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
| Revenue | $1.5B | $1.6B | $1.8B | $2.0B |
| Net income | $93.4M | $136.8M | $237.1M | $251.6M |
| Operating cash flow | $191.9M | $295.8M | $337.9M | $470.4M |
| Free cash flow | $165.9M | $246.9M | $287.6M | $392.7M |
Revenue, FY2017 to FY2026
Ten fiscal years, each from its own 10-K · XBRL · USD
$2.0B ▲ 9.3% in FY2026$251.6M ▲ 6.1% in FY2026$392.7M ▲ 36.6% in FY2026
Recent filings
5 filings in the last 30 days · SEC EDGAR
-
8-KNov 13, 2026Director or officer change, Shareholder vote results (amended) 8-K items 5.02, 5.07
-
Planned saleOct 29, 2026Mr. Robert Phelan (Senior Vice President and Chief Financial Officer) adopted a 10b5-1 trading plan reported in the 10-Q, up to 22,000 shares, runs to Sep 24, 2027
-
Planned saleOct 29, 2026Mr. Stephen W. Beard (Chairman and Chief Executive Officer) adopted a 10b5-1 trading plan reported in the 10-Q, up to 112,859 shares, runs to May 28, 2027
-
8-KOct 29, 2026Quarterly results 8-K item 2.02
-
10-QOct 29, 2026Quarterly report (10-Q) period ended Sep 30, 2026
About the company
Covista Inc., Chicago, IL · from the 10-K filed Aug 6, 2026
Covista is America’s largest healthcare educator, serving 100,000 students and supported by an alumni network of 400,000 across five accredited institutions: Chamberlain University (“Chamberlain”), Walden University (“Walden”), American University of the Caribbean School of Medicine (“AUC”), Ross University School of Medicine (“RUSM”), and Ross University School of Veterinary Medicine (“RUSVM”). Covista delivers education to its students at multiple campuses and online.
- Headquarters
- Chicago, IL
- Country
- United States
- Reports in
- USD
- Listed on
- NYSE
- Fiscal year ends
- June 30
- Last results
- Oct 29, 2026
- Incorporated in
- DE
Email alerts
Sources
The 10-K filed Aug 6, 2026 (open at SEC), compared with the 10-K filed Aug 7, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.
Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CVSA/export.csv") into a cell.